Patients with chronic obstructive pulmonary disease (COPD) may beat increased riskofaspiration secondary to impaired swallowfun ction. Onepossible cause of this impairmentisa reductionin laryngopharyngeal sensitivity. The relationship between COPD and laryngopharyngealsensitivity has not been previously determined. We conducted a study to investigate the effect of COPD on laryngopharyngeal sensitivitybyusinglaryngopharyngeal sensory discrimination testing (LPSDT). Ourstudypopulation was made up of20 adults(mean age: 71.7 yr) with clinicallyprovenCOPDand11healthy,age-matched controls. A1l31 subjects underwentLPSDTwith the useofan air-pulse stimulatorvia a nasendoscope. The threshold of laryngopharyngeal sensation wasevaluated bymeasuring the amount of airpressure required to elicit the laryngeal adductor reflex (LAR). Wefound that the patients with COPD had a significantly higher LAR threshold than did the controls (p < 0.001). We conclude that patients with COPD have significantly less mechanosensitivity in the laryngopharynx. This sensory change mayplace patients with COPD at increased riskfor aspiration.
Introduction
Chronic obstructive pulmonary disease (COPD) is the fourth-leading cause of death in the United States and Europe, and mortality among women as a result of COPD has more than doubled during the past 30 From the Speech Pathology Department (Ms. Clayton) years.' COPD is reportedly the only principal cause of death whose prevalence is increasing,' and the burden ofCOPD is likely to worsen as the population continues to age. Indeed, hospitalization rates for COPD patients increase with age. The primary goals of hospitalization are to provide supportive care and to monitor drug therapy. The increasing demands on the healthcare system justify further research within this population to facilitate more effective management. COPD patients commonly exhibit signs of malnourishment. Studies have indicated that 24% of COPD outpatients) and 47% ofCOPD inpatients' have a body weight less than 90% of their ideal weight. Dysphagia is often a precipitating factor for malnutrtnon.' Other possible factors include (1) the development of cachexia as a result ofmetabolic changes and (2) multiple periods of fasting as a prelude to procedures or investigations."
To date, relativelylittle research has been conducted on the prevalence of dysphagia and other swallowing disorders in patients with COPD. The reported prevalence of dysphagia in COPD patients varies considerably-from 17 to 85%.7.8 Some investigations have suggested that COPD may weaken the strength of swallow't'? and increase the prevalence of pulmonary aspiration. " When combined with an impaired ability to use expired air to clear the larynx and protect the airway, a weak swallow may contribute to an increased risk for aspiration of pharyngeal contents, which in turn can lead to aspiration pneumonia. Although a range of abnormalities in swallowing function has been reported in patients with COPD who have frequent exacerbattons.!? the basis for the dysphagia is uncertain. One hypothesis is that a laryngopharyngeal sensory deficit exists.
Laryngopharyngeal sensory deficits in patients who have experienced a stroke have been reported to be predictive of aspiration pneumonia.":" More impor-ENT·Ear, Nose & Throat Journal" September 2012 ~; f Jil l , l l U e :O I j ,~' " r1n:1I;' I : J l rn : : ' l i F l J ) Surgery ' CutllngEdge \ t ._~_. .
Howa little lube can have big impact.

Electrouutery lubricant
Electro lube Device Spotlight: ENTSuction Cauterv
Avoid the infamous effects of sticking and eschar buildup that accompany the cauterization of tissue and vessel structures.
ENT surgeons use Electro Lube on their suction cautery devices to preventsticking and clogging. They have found thiscuts their procedure time significantly by practically eliminating the stopping and starting normallyassociated with suction cautery in adenoid, tonsil, and thyroid procedures.
Electro Lubeisalso effective on bipolarforceps. By preventing sticking, thereisless tearing of tissue, less re-cautertzation, and ultimatelymoreefficient vessel seals. • a baseline forced expiratory volume in 1 second (FEV) measurement ofless than 70% of predicted;
• clinically stable COPD-that is, an absence of exacerbations for at least 6 weeks-as determined by a senior thoracic physician (A.I.I.); and
• respiratory failure on blood gas criteria-that is, an arterial oxygen pressure (Pa0 2 ) ofless than 60 mm Hg or an arterial carbon dioxide pressure (PaC0 2 ) of more than 50 mm Hg.
as determined by the LAR threshold in patients with proven COPD and (2) to characterize the relationship between laryngopharyngeal sensory impairment and the severity of COPD.
Inclusion criteria. The criteria for study eligibility were:
Sex, n (%) Men
Women
Patients and methods
The primary goals of our study were (1) to identify the prevalence of laryngopharyngeal sensory impairment tant, a laryngopharyngeal sensory deficit Table 1 . Selected patient characteristics without clinical evidence of dysphagiathat is, a silent sensory deficit-may be hazardous because it is likely to escape Variable detection and to predispose the patient Age, yr, mean ± SO to silent aspiration."
Additionally, conventional clinical techniques used to assess laryngopharyngeal sensory deficits, such gag reflex testing, seem to be of questionable value. The gag reflex test measures the FEV 11 % of predicted, activity of the glossopharyngeal nerve mean ± SO (cranial nerve IX) rather than the superior laryngeal branch of the vagus nerve Key: NS =not statistically significant; NIA =not applicable (cranial nerve X), which innervates the hypopharynx and larynx. Moreover, some research has shown that the gag reflex test is not a useful predictor of laryngopharyngeal sensitivityor aspiration pneumonia." A more sensitive test is required.
Laryngopharyngeal sensory discrimination testing (LPSDT) is a safe, reproducible method of identifying patients with laryngopharyngeal sensory deficits and hence those at increased risk for pulmonary aspiration.":" With this test, the integrityoflaryngopharyngeal sensitivity is determined by identifying the threshold at which the laryngeal adductor reflex (LAR) is triggered in response to air-pulse stimuli. The LAR represents the transient adduction of the true vocal folds in response to a mechanical stimulus. This reflex is designed to protect the lower airway from foreign material (food, fluid) and noxious stimuli (hot air, gases).
Laryngopharyngeal sensitivity as measured by LPSDT has been determined in normal subjects," in patients after stroke,12 and in patients with proven gastroesophageal reflux disease (GERD).17 However, it is not known whether laryngopharyngeal sensitivity as measured by LPSDT is abnormal in patients with COPD and, if it is, whether such an impairment predicts the presence of a swallowing disorder or pulmonary aspiration.
A simple, reproducible test of laryngopharyngeal sensitivity that would potentially predict which COPD patients are at highest risk for swallowing disorders and aspiration would be clinically useful and would allow clinicians to initiate preventive measures earlier. Therefore, we evaluated LPSDT to determine if it fills these needs.
DIGITAL STROBOSCOPY
• Indispensable tool for assessing vocal fold structure and vibratory characteristics
• Superior image quality with KayPENTAX rigid , fiberoptic, or distal-chip laryngoscopes • a history of head and neck surgery; • a neurologic impairment or progressive neurologic disease, including traumatic brain injury and bulbar or pseudobulbar palsy; and • a diagnosis ofGERD or reported clinical symptoms ofGERD.
These conditions are known to be associated with swallowing disorders and impaired laryngopharyngeal sensitivity.
Patients and controls. Once potential participants were judged to have met all eligibility criteria, the y were approached for consent to participate. Patients had been recruited through one of two methods:
• We consulted hospital adm issions lists to identify patients who had been admitted under the care of respiratory physicians or who were admitted to the respiratory ward. These patients had been hospitalized for treatment of exacerbations of their illness or for some other medicalor surgical reason.
• We consulted lists of outpatients of visiting thoracic physicians. All potential candidates had their medical records examined by the study's speech pathologist (N.A.C.), who determined their eligibility for inclusion in the study.
Controls were recruited from a variety of sources: hospital staff,family members of the researchers, and current orthopedic patients at Concord Repatriation General Hospital in Concord, New South Wales, Australia.
During the study period, 33 participants were recruited: 22 patients and 11 controls. Two of the COPD patients were unable to tolerate LPSDT, and they were dropped from the studyand their data were not included in our results, leaving us with 20 COPD patients-16 men and 4 women, aged 54 to 80 years (mean: 71.7). The control group was made up of7 men and 4 women, aged41 to 79years (mean: 70.4).The differences between age and sex in the two groups were not statistically significant (table 1) .
Laryngopharyngeal sensitivity testing. Preparation for LPSDT involved the topical application of viscous lidocaine to both nares to facilitate tolerance of the nasendoscopy. Anesthetic spray was not used because it might have influenced the results of sensory testing. The nasendoscope (FNL-10 AP;KayPENTAX; Montvale, N.J.)was attached to an air-pulse sensorystimulator (AP-4000; KayPENTAX), and it was then passed transnasally through to the laryngopharynx until it became situated 374" www.entJournal.com approximately 3 mm above the arytenoid eminence.
Establishing the presence of light reflection from the nasendoscope onto the arytenoid eminence in addition to deflection of arytenoid tissue when an air pulse was triggered allowed us to correctly position the nasendoscope and thereby ensure the accuracy of the distance between the scope and the arytenoid eminence. Air pulses of 50 ms in duration were delivered to the arytenoid eminence, initially at a pressure of 6.0 mm Hg in accordance with the descending and ascending threshold testing protocol described by Aviv et al in 1993.
14 If the LARwas triggered at 6.0 mm Hg, the pressure of the pulses was reduced in O.5 -mm Hg increments until the reflex was no longer observed. At that point, air pressure was then increased in 1.0-mm Hg increments until the reflex was observed again.
If no LARwas triggered at 6.0 mm Hg, air pulses were increased in 1.0-mm Hg increments until the reflex was observed. Once the reflex was elicited, air pulses were systematically reduced byO.s mrn Hg until the reflex was no longer observed. The LAR threshold was defined as the lowest air pressure that tr iggered the reflex on three separate occasions.
The air-pulse sensory stimulator we used was unable to generate air pulses greater than 9.9 mm Hg. So for the purposes of this study, if no LAR was observed at 9.9 mm Hg, the duration of the air pulse was extended from 50 ms to 1.0 sec at 9.9 mm Hg. If a response was still not elicited, the LAR threshold was determined to be 9.9 mm Hg.
Testing was conducted unilaterally only because none of the COPD patients was considered to be at risk of asymmetrical sensory impairment in view of the absent history of neurologic disease and head/neck pathology. The physician performing LPSDT (A.J.!.) was blinded to the patient's level of lung function abnormality, but not to the COPD diagnosis.
For LPSDT, patients sat upright in a chair. They were not informed about the ascending and descending nature of the air-pulse pressures. The air pulses were delivered at irregular intervals so that the patients could not know or anticipate when each would be administered.
Controls. All the control subjects were recruited for the purpose of determining normal lar yngopharyngeal sensation. Each control provided a detailed medical history that included information that would be useful in identifying a potential swallowing disorder. Potential controls were excluded if theyhad a history of neurologic disease, respiratory disease, dysphagia, GERD, smoking, abnormal lung function as measured by spirometry, or 5.5 4.5 to 9.9 2.5 to 9.9
8.57 to 9.97 4.08 to 6.72 ranged from 2.5 to 9.9 mm Hg (mean: 5.40; median: 5.5; 95% CI: 4.08 to 6.72) ( figure 1, table 2) . The difference between the two groups was statistically significant (p < 0.001) according to the independent samples t test where equal variance was assumed (Levene test for equality of variances). LPSDT and FEVI data were reviewed to identify the pre sence of any relationship using the Pearson productmoment co rrelation coefficient. No significant correlation was identified between laryngopharyngeal sensitivity and FEV t (r = 0.240; P =0.308) (figure 2). 
Discussion
Analysisofresults. Our null hypothesis
was that there is no difference in laryngopharyngeal sensitivity between COPD patients and healthy controls. Based on the findings of a previous pilot study. in which a difference of0.5 mm Hg (±0.32) was seen between COPD and healthy populations, we conducted a sample size calculation based on a = 0.05 and p = 0.10 (power =90%). Using these values, we determined that we would need a minimum of 14 COPD patients to test our null hypothesis. Our da ta were entered into a Microsoft Excel spreadsheet (Microsoft; Redmond, Wash.), and statistical analys is was for th e Social Sciences software (v. 11.0; SPSS; Chicago). All data were tabulated and reviewed descriptively for completeness and distribution. In view of non-normal distributions and our limited sample size, nonparametric methods were used to evaluate the relationship bet ween the primary outcome (LAR threshold) and all other endpoints.
Means, modes, and standard deviations were derived for allvariables. Groups were then compared for variables such as age, sex, admission diagnosis, and resp iratory function. Any differences between the groups were sought using odds ratios with 95% CIs applied.
Cross-tabulation and the Fisher exact test were employed to examine the relationship between the categoricalendpoints ofeach group:FEVI values, age, and sex. The Mann Whitney Utest, which is the nonparametric t test for independent samples, was employed to evaluate the relationship between the LAR threshold and each group.
Ethicalconsiderations. All procedures were approved by the Concord Repatriation General Hospital's Resea rch and Ethics Commit- Table 2 . Laryngeal adductor refle x th resholds in th e two gro ups tee . All study patients provided written infor m ed consent.
Threshold, mmHg
Results
The LAR th resh old s for the COPD patients ranged from 4.5 to 9.9 m m Hg (mean: 9.27; median: 9.9; 95% CI: 8.57 to 9.97). For the control group. thresholds ment error at 0.34 and a coefficient of variation at 9.7%; additionally, test repeatability was 0.96. Our study revealed that patients with COPD have a significantly worse level of laryngopharyngeal sensory impairment as defined by the LAR threshold compared with healthy controls (p < 0.001). Impaired laryngopharyngeal sensitivitymay be clinically important in COPD patients, who have high rates of hospitalization related to lower respiratory tract infections. In fact, impaired sensitivity may be partly responsible for the higher incidence of these complications in COPD patients.
A number of researchers have completed studies examiningthe effectofimpairedlaryngopharyngeal sensitivity on the risk for aspiration and aspiration pneumonia. In 1997, Avivet al evaluated laryngopharyngeal sensitivity testing by using the modified barium swallow test as a predictor of aspiration pneumonia after stroke." They found that the combination of the two tests was useful in predicting which patients were at high risk for developing aspiration pneumonia. They also reported that those patients who had bilateral sensory deficits (as defined by LPSDT) had the greatest risk for developing pulmonary complications secondary to aspiration, regardless of whether or not they showed evidence of aspiration on a modified barium swallow examination.
In our study, 19 of 20 COPD patients (95%) demonstrated impaired laryngopharyngeal sensitivity as indicated by a LAR threshold of 5.0 mm Hg or higher. This high proportion suggests that these patients may be at increased risk for developing aspiration pneumonia.
In 2001, Setzen et al reported the results of their study oflaryngopharyngeal sensory deficits as a predictor of aspiration." They examined pharyngeal muscle contraction and aspiration in 40 patients with dysphagia. Their results revealed that patients with no LARhad a higher incidence of aspiration and pharyngeal muscular weakness than did controls with normal laryngopharyngeal sensitivity. They concluded that a strong relationship exists between sensory loss and motor deficits, and that these two features may be used to predict those patients at greater risk for aspiration. Their results suggest that the COPD patients in our study may be at increased risk for both aspiration and impaired pharyngeal muscle strength. Further studies to examine the relationship between laryngopharyngeal sensitivity and pharyngeal muscle strength in patients with COPD would be beneficial.
As an extension of the studyby Setzen et al," Avivet aF2 investigated LAR and pharyngeal squeeze (a technique designed to assess the integrity of pharyngeal muscle contraction) as predictors oflaryngeal penetration and aspiration. Aviv et al also reported a strong association between motor and sensory deficits, and they concluded that patients with no LAR were more likely to demonstrate laryngeal penetration and aspiration than were those in whom LAR was intact (p < 0.0001).
Avivet al also reported a significant difference in the integrity of pharyngeal muscular contraction (as defined by pharyngeal squeeze) between the two groups." Those patients with no LAR had a higher incidence of impaired pharyngeal squeeze (p < 0.0001) than did the patients with an intact reflex. The findings of Aviv et al further suggest that the COPD patients in our study may have an increased risk for impaired pharyngeal muscle strength and aspiration.
Setzen et aFJ in 2003 
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Integrated LED light source More brightness where it counts: at the end of the scope pharyngeal motor function, severe laryngopharyngeal sensory deficits were associated with aspiration of thin liquids (p <0.05).23 Perlman et al concluded that patients with impaired pharyngeal motor function at different levels of sensory loss had a higher risk for aspiration of pureed foods than did subjects with normal pharyngeal motor function. " Furthermore, they suggested that hypopharyngeal muscle tone may be a better predictor ofaspiration of pureed foods than is laryngopharyngeal sensation.
'[h e implications for our study are that although laryngopharyngeal sensitivity deficit in COPD may be indicative of a higher aspiration risk, an additional assessment of pharyngeal muscle strength may further reinforce the evidence suggesting an elevated risk for aspiration.
While our study demonstrated a high incidence of lar yngopharyngeal sensory impairment in patients with COPD, the integrity of pharyngeal motor function in this population remains unknown. Investigators contemplating future studies should consider examining the relationship between laryngopharyngeal sensitivity, pharyngeal squeeze, and swallow function in COPD patients.
In our study, no relationship was identified between the severity of laryngopharyngeal sensory impairment (as defined by the LAR threshold) and the severity of COPD (as defined by FEV) testing). While the diagnosis ofCOPD was strongly related to laryngopharyngeal sensoryimpairment, the severity ofCOPD did not correlate with deterioration in laryngopharyngeal sensitivity. This may imply that the presence of COPD itself is enough to predict impairment oflaryngopharyngeal sensitivity.
A future study that involves a larger sample size and a study population that includes non-COPD subjects with a similar percentage of predicted FEV1 values might be able to determine if a relationship exists . Additionally, if LAR thresholds can be more accurately determined in the upper range (should LPSDT be modified to reflect pressures greater than 9.9 mm Hg), the nature of any relationship might be further clarified.
For our study, we attempted to remove age as a possible confounding factor. COPD typically occurs in older populations because lung dam age from tobacco use takes a period of time to present as an airways disease. The mean age of the COPD patients in our study was fairly high (71.7 yr) . Therefore, we age-matched our healthy control group to the COPD group in an effort to ensure that any difference in laryngopharyngeal sensitivity between the two groups could not be attributed to age alone .
• www.entjournal.com
Our study demonstrated that COPD patients exhibited a significant reduction in mechanosensitivity in the laryngopharynx. 'Ihe cause of thi s sensory impairment may be related to a number ofvariables. For example, the effect ofinhaled corticosteroids and inhaled anticholinergics on lar yngopharyngeal sen sation is unknown. These medications are used widely in COPD management, and they may have an unknown effect on the sensory mucosa in the laryngopharynx. Active smoking and the pre sence of chronic cough resulting in laryngeal edema are commonly reported in COPD patients; such edema may be a contributing factor to reduced sensation.
Finally, GERD is known to inhibit laryngopharyngeal sensitivity," While patients with symptomatic GERD were excluded from our study, the presence of occult GERD cannot be ruled out. Future research efforts should attempt to account for the presence of GERD by requiring 24-hour ambulatory esophageal dual-channel pH manometry as a part of any study protocol.
In conclusion, our study has revealed that the laryngopharyngeal sensation of patients with COPD was significantly impaired, suggesting that this population may be at increased risk for aspiration. Additional longer-term investigations of the outcomes of COPD patients with this impairment are warranted.
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